/GMTX

GMTX Stock - Gemini Therapeutics, Inc.

Q: What is the analyst price target for GMTX?

Analyst price target information is not currently available for GMTX.

Q: What is GMTX's market cap?

Market capitalization information is not currently available for GMTX.

Healthcare|Biotechnology|NASDAQ

$1.35+0.00%

+$0.00 (+0.00%) • Dec 30

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $1.49

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GMTX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Earnings History & Surprises

GMTX

Beat Rate

60%

Last 5 quarters

Avg Surprise

-8.8%

EPS vs Estimate

Beats / Misses

3/2

Last 12 quarters

Latest EPS

$-1.60

Q3 2022

EPS Surprise History

Q2 21

-61.6%

$-5.90vs$-3.65

Q3 21

+5.0%

$-3.80vs$-4.00

Q4 21

+9.1%

$-4.30vs$-4.73

Q2 22

-16.3%

$-3.50vs$-3.01

Q3 22

+20.0%

$-1.60vs$-2.00

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2023	Mar 8, 2023	—	—	—	—
Q4 2022	Nov 10, 2022	—	—	—	—
Q3 2022	Aug 11, 2022	$-2.00	$-1.60	+20.0%	✓ BEAT
Q2 2022	May 6, 2022	$-3.01	$-3.50	-16.3%	✗ MISS
Q4 2021	Nov 15, 2021	$-4.73	$-4.30	+9.1%	✓ BEAT
Q3 2021	Aug 12, 2021	$-4.00	$-3.80	+5.0%	✓ BEAT
Q2 2021	May 13, 2021	$-3.65	$-5.90	-61.6%	✗ MISS
Q1 2021	Jan 19, 2021	—	—	—	—

Frequently Asked Questions about GMTX

What is GMTX's current stock price?

Gemini Therapeutics, Inc. (GMTX) is currently trading at $1.35 per share. The stock has moved +0.00% today.

What is the analyst price target for GMTX?

No analyst price targets are currently available for this stock.

What sector is Gemini Therapeutics, Inc. in?

Gemini Therapeutics, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is GMTX's market cap?

Gemini Therapeutics, Inc. has a market capitalization of $0.03 billion, making it a small-cap company.

Does GMTX pay dividends?

No, Gemini Therapeutics, Inc. does not currently pay a dividend to shareholders.